About NeuroSense Therapeutics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
1 Broadway,Cambridge,Massachusetts,US
Description
Information
Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.

NeuroSense Therapeutics Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
biotechnology
Industry
Biotechnology

Frequently Asked Questions about NeuroSense Therapeutics

What is NeuroSense Therapeutics email format?

The widely used NeuroSense Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is NeuroSense Therapeutics customer service number?

To contact NeuroSense Therapeutics customer service number call here +972-9-9531142. To contact NeuroSense Therapeutics customer service number in your country click here to find.


Who is the CEO of NeuroSense Therapeutics?

Alon Ben-noon is the CEO of NeuroSense Therapeutics. To contact Alon Ben-noon email at [email protected] or [email protected]. Or you may call +972523757325


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more